Risk of Stevens-Johnson Syndrome with AED Therapy

J Gordon Millichap

doi:10.15844/pedneurbriefs-13-7-8

Risk of Stevens-Johnson Syndrome with AED Therapy

Pediatric Neurology Briefs

Volume 13 (1999): Issue 7

By: J Gordon Millichap

Open Access

|Jul 1999

Abstract

The role of antiepileptic drugs in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) was evaluated in a case-control study in Europe and reported from Mannheim, Germany.

References

Rzany B Correia O Kelly JP Naldi L Auquier A Stern R Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions Lancet 1999 Jun 26 353 9171 2190 2194 10.1016/S0140-6736(98)05418-X 10392983
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-13-7-8 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 53 - 54

Published on: Jul 1, 1999

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Antiepileptic Drugs,

Stevens-Johnson Syndrome,

Toxic Epidermal Necrolysis

© 1999 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 13 (1999): Issue 7